Novocure Round-Trips Its Recent Breakout After Announcing A Series Of C-Suite ChangesInvestors Business Daily • 01/19/23
Novocure Has Fallen More Than 20% Over Seven Days — Why It Fell From GraceInvestors Business Daily • 01/17/23
Novocure Announces Preliminary Full Year and Fourth Quarter 2022 Net Revenues and Provides Company UpdateBusiness Wire • 01/09/23
Novocure, Zai shares rally after lung-cancer treatment meets primary endpoint in studyMarket Watch • 01/05/23
Novocure Announces Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival EndpointBusiness Wire • 01/05/23
Novocure's Optune® Approved in Canada for the Treatment of Newly Diagnosed and Recurrent GlioblastomaBusiness Wire • 11/29/22